Professional Documents
Culture Documents
337
doi:10.1042/BJ20131620
INTRODUCTION
Abbreviations: AA, arachidonic acid; AOX1, alcohol oxidase 1; CHO, Chinese-hamster ovary; cytb 558 , flavocytochrome b 558 ; DDM, n-dodecyl-DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; DPI, diphenyliodonium; FRE1, ferric reductase 1; Ni-NTA, Ni2 + -nitrilotriacetate; NOX2,
NADPH oxidase 2; PL, proteoliposome; PNGase F, peptide N-glycosidase F; SH3, Src homology 3; SOD, superoxide dismutase.
1
To whom correspondence should be addressed (email laura.baciou@u-psud.fr).
D-maltoside;
c The Authors Journal compilation
c 2014 Biochemical Society
Biochemical Journal
www.biochemj.org
*Laboratoire de Chimie Physique, Universite Paris Sud, UMR8000 CNRS, Bat. 350, 91405 Orsay Cedex, France
338
Cell pellets were thawed, broken using glass beads and membrane
fractions were collected by centrifugation at 100 000 g for 120 min
at 4 C. The pelleted membrane fractions were resuspended in
50 mM Tris/HCl (pH 8), 120 mM NaCl, 10 % glycerol and 1 mM
PMSF and loaded on to a discontinuous sucrose gradient (60 %,
40 % and 20 % sucrose) as described previously [20]. After
overnight centrifugation at 110 000 g, the essential pure plasma
membranes were removed from the 60 % and 40 % interface,
diluted 4-fold and pelleted at 130 000 g for 90 min. The cytb558 enriched plasma membrane fraction were resuspended in 1 mM
EDTA, 30 % sucrose and 20 mM Tris/HCl (pH 8.0) and stored
at 20 C. Reduced-minus-oxidized spectra were performed
using a double beam Uvikon 943 spectrophotometer (Kontron
Instruments). Excess dithionite was added to the cuvette to
reduce the sample before obtaining the spectra. The absorbance
difference between the peak at 428 nm and the trough at
411 nm was used to determine the cytb558 concentration using
the molar absorption coefficient 428411 = 200 mM 1 cm 1 [21].
Deglycosylation was performed with the PNGase F (peptide Nglycosidase F; New England Biolabs) treatment as described by
the manufacturer.
For the Western blotting assay, anti-His antibody conjugated to
HRP (horseradish peroxidase; Clontech), rabbit anti-gp91 (54.1)
and anti-p22 (FL-195) antibodies (Santa Cruz Biotechnology)
were used for specific identification at a dilution of 1:1000. Antirabbit (NA934V; GE Healthcare) and anti-mouse (NA931; GE
Healthcare) IgG monoclonal antibodies were used at a 1:15 000
dilution as secondary antibodies to detect the anti-gp91 and antip22 primary antibodies respectively. Signal development was
performed by the ECL Plus Advance Western Blotting Detection
Kit (GE Healthcare).
NADPH oxidase activity in cell-free assay
RESULTS
Gp91phox maturation is partially determined by the presence of
p22phox
Figure 1
339
Constructs in X33 Pichia strains and analysis of the expression and glycosylation of recombinant gp91phox
(A) Transgenic Pichia strains X33/ Hisgp91, X33/ Hisp22 and X33/ Hisgp91/p22His were obtained by the integration of the respective recombinant vectors pPICZA/His-gp91phox ,
pPICZA/His-p22phox and a chimaeric pPICZA/His-gp91phox /p22phox in the genomic DNA of P. pastoris cells strain X33 respectively. (B) Western blots analyses (anti-His antibodies) of
membrane fractions. Lane 1, X33/ (control strain containing the empty vector); lane 2, X33/ gp91; and lane 3, X33/ gp91p22. All fractions were recovered from cells cultured for 72 h. (C)
Deglycosylation of the recombinant gp91phox with the PNGase F. The membrane expressing gp91phox (lane 1) was treated by 10 units of enzyme PNGase F under denaturing conditions (lane 2).
Proteins were detected by Western blot analysis using the monoclonal anti-gp91 antibody (54.1).
340
Figure 2
Activity assays were performed in a cell-free system using membrane fractions expressing gp91phox (2.24 nM) incubated for 5 min in the presence of recombinant cytosolic proteins [p47phox
(0.89M), p67phox (0.42 M) and Rac1Q61L (0.34 M)]. All results in this Figure are means +
S.D. of three independent experiments (n = 3). (A) Activation of NADPH oxidase complex by AA of
gp91phox and of gp91phox /p22phox . Activities with gp91phox (black line) or heterodimer gp91/p22 (dashed line) membrane fractions (3 g and 8.25 g of total membrane proteins respectively) were
determined using standard cytochrome c assays, as described above, after the addition of 400 M NADPH at different cis -AA concentrations. (B) Kinetic parameters of the gp91phox . Activity assays
were performed in a cell-free system in the presence of cis -AA (650 M). The reaction was initiated by the addition of increasing concentrations of NADPH in the presence of 100 M cytochrome c .
The fitting of the determined values and K m and V max calculation were performed by Origin software. (C) NADPH oxidase inhibition by DPI. Two different concentrations of DPI (200 and 400 M) were
used to determine its inhibitory potential on the NADPH oxidase activity. Assays were carried out under the same conditions as described above except that an optimal concentration of AA (650 M)
was used. Results are means +
S.D. of three independent experiments (n = 3). Statistical analysis for multiple comparisons was performed with GraphPad software. ***P < 0.001, compared with
the control using one-way ANOVA followed by Dunnetts test.
Figure 3
341
Activation of gp91phox by the cytosolic subunits and co-sedimentation analysis with membranes expressing gp91phox
In a 500 l total reaction volume, 3 g of membrane protein fractions (containing 2.24 nM of gp91phox ) were incubated for 5 min in the presence of recombinant cytosolic proteins [p47phox (0.89 M)
and/or p67phox (0.42 M) and/or Rac1Q61L (0.34 M)]. (A) Superoxide production determined in a cell-free system with alternative presence of cytosolic subunits. Results are means +
S.D. of three
independent experiments (n = 3). Statistical analyses for multiple comparisons were performed with GraphPad software using one-way ANOVA followed by Tukeys test in order to pinpoint where the
real differences lie. ***P < 0.001 and *P < 0.05 compared with the control (entire complex); + + P < 0.01 for comparison within each group (i.e. only one cytosolic protein added or two by two);
and $P < 0.05 and $$$P < 0.001. n.s., not significant difference. (B) The cytosolic proteins were incubated independently or together in the presence of AA (650 M) with either X33 /gp91phox
or X33 / membranes. After sucrose gradient separation, the cytosolic proteins translocated to the pelleted membrane (membrane-assembled fractions; AF) or remained in the supernatant of the
sucrose gradient (S) were revealed by Western blotting with anti-p47phox , anti-p67phox or anti-Rac1 antibody. Experiments were repeated twice.
342
Purified fractions of gp91phox were incubated with membranes prepared from X33 / cells or
X33 cells expressing only p22phox (X33/ p22) for 45 min and then used for cell-free assays.
The same quantity of protein was used in all measurements. In addition, we used the maximum
concentration of activating AA (650 M) and NADPH (400 M) in these measurements. Activity
measurements with the dimer gp91p22 were considered as the reference for 100 % activity.
Type of membrane tested DDMgp91phox Mol of O2 /s per mol of gp91phox Activity (%)
Figure 4
(A) SDS/PAGE analysis. The total membrane fraction (25 g; lane 1) was solubilized in 2 %
DDM and the recombinant gp91phox protein was purified on a Ni-NTA column (lane 2) followed
by gel filtration (15 g; lane 3). Gels were stained with Coomassie Blue. (B) The characteristic
peaks of the purified protein were identified in the reduced-minus-oxidized spectral analysis
using sodium dithionite. (C) Following SDS/PAGE separation of 15 g of purified protein and
transfer on to membranes, specific identification by the monoclonal anti-gp91 antibody (54.1;
Santa Cruz Biotechnology). M, Magic Mark standard protein (Invitrogen) used as a molecular
mass reference.
X33 /
X33 /p22
X33 /
X33 /p22
X33 /gp91p22
X33 /gp91
+
+
7.5 +
5.4
8+
6.3
116.1 +
3.2
149.2 +
4.5
198.5 +
7
181 +
5
20 +
3.6
3.7
4
58.4
75
100
91.4
10
DISCUSSION
Figure 5
Measurements of the superoxide production by PLs (2.24 nM of gp91phox ) were performed in a cell-free system using a standard cytochrome c reduction assay in the absence of any cytosolic
proteins and increasing concentrations of AA. For comparison the activation curve obtained with the gp91phox membrane fraction (Figure 2A) is also shown. Results are means +
S.D. (n = 3).
c The Authors Journal compilation
c 2014 Biochemical Society
343
344
Figure 6 Schematic representation of the active gp91phox subunit and potential interactions with cytosolic proteins in the absence of p22phox in P. pastoris
membranes
The p67phox subunit bind to the dehydrogenase domain allowing interaction of its activation domain (AD) required for NADPH oxidase activation [53], but, in the absence of p22phox , it must be
tethered (Rac or p47phox ) to be stabilized at the membrane. This can be accomplished via a tail-to-tail interaction involving the SH3 domain of p67phox and the proline-rich region (PRR) in the
C-terminal region of p47phox . p67phox contains four tetratricopeptide (TPR) motifs which create a binding surface for activated Rac. p47phox contains the regulatory PX (phox homology) domain that
binds phosphoinositides as well as tandem SH3 domains for binding its target PxxP motif in p22phox . In the absence of p22phox , the p47phox subunit might interact directly with gp91phox through two
putative binding sites of in the C-terminal region of gp91phox as predicted in [54].
AUTHOR CONTRIBUTION
Aymen Ezzine and Laura Baciou designed the research; Aymen Ezzine and Hager Souabni
performed the research; Aymen Ezzine, Hager Souabni, Tania Bizouarn and Laura Baciou
analysed the data; and Aymen Ezzine and Laura Baciou wrote the paper.
ACKNOWLEDGEMENT
We thank Florence Lederer for stimulating discussions and careful reading of the paper
before submission.
FUNDING
This work was supported by the Agence Nationale de la Recherche [project number
ANR-2010-BLAN-1536-01].
c The Authors Journal compilation
c 2014 Biochemical Society
REFERENCES
1 Cross, A. R., Rae, J. and Curnutte, J. T. (1995) Cytochrome b -245 of the neutrophil
superoxide-generating system contains two nonidentical hemes. Potentiometric studies
of a mutant form of gp91phox . J. Biol. Chem. 270, 1707517077 CrossRef PubMed
2 Sumimoto, H. (2008) Structure, regulation and evolution of Nox-family NADPH oxidases
that produce reactive oxygen species. FEBS J. 275, 32493277 CrossRef PubMed
3 Fujii, H., Finnegan, M. G. and Johnson, M. K. (1999) The active form of the ferric heme in
neutrophil cytochrome b 558 is low-spin in the reconstituted cell-free system in the
presence of amphophil. J. Biochem. 126, 708714 CrossRef PubMed
4 Fujii, H., Finnegan, M. G., Miki, T., Crouse, B. R., Kakinuma, K. and Johnson, M. K.
(1995) Spectroscopic identification of the heme axial ligation of cytochrome b 558 in the
NADPH oxidase of porcine neutrophils. FEBS Lett. 377, 345348 CrossRef PubMed
5 Vignais, P. V. (2002) The superoxide-generating NADPH oxidase: structural aspects and
activation mechanism. Cell. Mol. Life Sci. 59, 14281459 CrossRef PubMed
6 Harper, A. M., Chaplin, M. F. and Segal, A. W. (1985) Cytochrome b -245 from human
neutrophils is a glycoprotein. Biochem. J. 227, 783788 PubMed
7 Borregaard, N., Heiple, J. M., Simons, E. R. and Clark, R. A. (1983) Subcellular
localization of the b-cytochrome component of the human neutrophil microbicidal
oxidase: translocation during activation. J. Cell Biol. 97, 5261 CrossRef PubMed
8 Huang, J., Hitt, N. D. and Kleinberg, M. E. (1995) Stoichiometry of p22-phox and gp91-phox
in phagocyte cytochrome b 558 . Biochemistry 34, 1675316757 CrossRef PubMed
9 Nauseef, W. M. (2004) Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol.
122, 277291 CrossRef PubMed
10 Cheng, G. J., Cao, Z. H., Xu, X. X., Van Meir, E. G. and Lambeth, J. D. (2001) Homologs
of gp91phox : cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131140
CrossRef PubMed
11 Dinauer, M. C., Pierce, E. A., Bruns, G. A. P., Curnutte, J. T. and Orkin, S. H. (1990)
Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal
location, and mutations in cytochrome-negative autosomal recessive chronic
granulomatous disease. J. Clin. Invest. 86, 17291737 CrossRef PubMed
12 Parkos, C. A., Dinauer, M. C., Jesaitis, A. J., Orkin, S. H. and Curnutte, J. T. (1989)
Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome-b in 2
genetic forms of chronic granulomatous disease. Blood 73, 14161420 PubMed
13 Stasia, M. J., Bordigoni, P., Martel, C. and Morel, F. (2002) A novel and unusual case of
chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA
gene (A22 ) leading to the activation of a cryptic splice site in intron 4. Hum.Genet. 110,
444450 CrossRef PubMed
14 Yu, L., Quinn, M. T., Cross, A. R. and Dinauer, M. C. (1998) Gp91phox is the heme binding
subunit of the superoxide-generating NADPH oxidase. Proc. Natl. Acad. Sci. U.S.A. 95,
79937998 CrossRef PubMed
345
c The Authors Journal compilation
c 2014 Biochemical Society
doi:10.1042/BJ20131620
Figure S1
Cell fractions were recovered every 24 h of methanol induction and reduced-minus-oxidized spectra of the total membrane fractions were determined. Green, control strain after the 72 h culture
period; blue, 24 h of culture; red, 48 h of culture; and violet, 72 h of culture.